Nycomed, Baxter get approval for Tachosil patch
Nycomed and its partner Baxter International Inc. said they received approval for TachoSil, a surgical patch, from the U.S. Food and Drug Administration as an adjunct to haemostasis in cardiovascular surgery.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.